Every material Form 8-K Ametek filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
AMETEK reported third quarter 2024 sales of $1.71 billion, up 5%, and adjusted diluted earnings of $1.66 per share, up 1%. The company raised its 2024 adjusted diluted EPS guidance to $6.77 to $6.82 from $6.70 to $6.80 and said it acquired Virtek Vision International, which has annual sales of about $40 million.
Q3 sales were $1.71 billion, up 5%; operating income rose 2% to $445.9 million.
GAAP diluted EPS was $1.47, flat year over year; adjusted diluted EPS was $1.66, up 1% from $1.64.
2024 adjusted diluted EPS guidance raised to $6.77 to $6.82; full-year sales growth outlook of 5% to 7% unchanged.
Virtek Vision, with annual sales of about $40 million, will join the Electronic Instruments Group.
AMETEK reported second quarter 2024 sales of $1.73 billion, up 5%, and operating income of $447.5 million, up 7%. The company also adjusted its 2024 sales and earnings guidance, citing ongoing inventory normalization at OEM customers and more cautious customers delaying project spending, and expects third quarter adjusted earnings per share to fall 1% to 2%.
Q2 2024 GAAP diluted EPS was $1.45 versus $1.40 a year earlier; adjusted EPS was $1.66, up 6%
Full-year 2024 sales are now expected to be up 5% to 7% versus 2023, with adjusted EPS of $6.70 to $6.80
Third quarter 2024 adjusted EPS is expected at $1.60 to $1.62, down 1% to 2% from the third quarter of 2023
Electromechanical Group sales rose 14% to a record $581.2 million, while its operating margin was 21.2%
AMETEK reported first-quarter 2024 sales of $1.74 billion, up 9% from a year earlier, and adjusted earnings of $1.64 per diluted share, up 10%. The company raised its 2024 adjusted earnings per share guidance to $6.74 to $6.86 from $6.70 to $6.85, which benefits shareholders if the outlook holds.
First-quarter sales of $1.74 billion, up 9% from the first quarter of 2023
GAAP diluted EPS of $1.34 versus $1.32 a year earlier; adjusted EPS of $1.64 versus $1.49
2024 adjusted EPS guidance raised to $6.74 to $6.86 from $6.70 to $6.85
Paragon Medical integration costs of $29.2 million pre-tax weighed on GAAP results
AMETEK reported record fourth-quarter 2023 sales of $1.73 billion, up 6.5%, and adjusted diluted earnings of $1.68 per share, up 11%, with full-year 2023 sales of $6.60 billion. The company expects 2024 sales to rise by low double digits and adjusted earnings of $6.70 to $6.85 per share, an increase of 5% to 7%, which gives shareholders a forward profit range.
Q4 2023 sales $1.73 billion, up 6.5%; operating margin 25.7%
AMETEK's Executive Vice President and Chief Financial Officer, William J. Burke, will retire effective April 2, 2024, and remain as a senior advisor through April 2025. The board named Dalip M. Puri, currently Senior Vice President, Operational Finance, to succeed him in the CFO role on the same date, a planned leadership transition that does not change reported financial results.
William J. Burke retires as CFO effective April 2, 2024, after 36 years with the company
Dalip M. Puri, 51, to become Executive Vice President and CFO effective April 2, 2024
Burke will stay on as a strategic advisor through April 2025 to support the transition
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Ametek filing is on SEC EDGAR ↗. 8-K briefs of other companies →